The "Trojan horse" model-delivery of anti-HBV small interfering RNAs by a recombinant HBV vector

被引:16
|
作者
Shlomai, Amir [1 ]
Lubelsky, Yoav [1 ]
Har-Noy, Ofir [1 ]
Shaul, Yosef [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel
关键词
Hepatitis B virus; RNAi; Recombinant virus; shRNA; B-VIRUS REPLICATION; HEPATITIS-B; NATURAL-HISTORY; INFECTION; INHIBITION; EXPRESSION;
D O I
10.1016/j.bbrc.2009.10.016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatitis B virus (HBV) is a small virus that infects the liver. The major obstacle in applying the RNA interference method as an anti-HBV weapon is the challenge to deliver the small interfering RNA molecules to the liver efficiently and specifically. Here we show that HBV-specific short hairpin RNAs (shRNAs) are efficiently expressed from a recombinant HBV into which an shRNA-expressing cassette was inserted, resulting in a significant knock-clown of HBV gene expression. Notably, this recombinant HBV still expresses the HBV Core protein, which is targeted by the shRNAs produced by the same vector. Our results set the stage for further use of this recombinant HBV Virus with the potential to function as a "Trojan horse"; one that specifically targets the liver and uses the resident virus as an helper for its own propagation, and at the same time eliminate itself and the resident HBV by knocking-down their gene expression. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:619 / 623
页数:5
相关论文
共 50 条
  • [1] Baicalin benefits the anti-HBV therapy via inhibiting HBV viral RNAs
    Huang, Hai
    Zhou, Wei
    Zhu, Haiyan
    Zhou, Pei
    Shi, Xunlong
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2017, 323 : 36 - 43
  • [2] Anti-HBV activity of TRL mediated by recombinant adenovirus
    Gong, Wei-Dong
    Zhao, Ya
    Yi, Jun
    Ding, Jin
    Liu, Jun
    Xue, Cai-Fang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (17) : 2574 - 2578
  • [3] A NOVEL, SMALL ANTI-HBV COMPOUND REDUCES HBsAg AND HBV DNA BY DESTABILIZING HBV RNA
    Watanabe, Takehisa
    Hayashi, Sanae
    Nagaoka, Katsuya
    Tanaka, Yasuhito
    HEPATOLOGY, 2022, 76 : S270 - S270
  • [4] Anti-HBV activity of TRL mediated by recombinant adenovirus
    Wei-Dong Gong
    World Journal of Gastroenterology, 2005, (17) : 2574 - 2578
  • [5] The anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-α
    Haotian Yu
    Zhaohua Hou
    Qiuju Han
    Cai Zhang
    Jian Zhang
    Virology Journal, 10
  • [6] The anti-HBV effect mediated by a novel recombinant eukaryotic expression vector for IFN-α
    Yu, Haotian
    Hou, Zhaohua
    Han, Qiuju
    Zhang, Cai
    Zhang, Jian
    VIROLOGY JOURNAL, 2013, 10
  • [7] A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA
    Takehisa Watanabe
    Sanae Hayashi
    Yan Zhaoyu
    Hiroki Inada
    Katsuya Nagaoka
    Masakuni Tateyama
    Yasuhito Tanaka
    Journal of Gastroenterology, 2024, 59 : 315 - 328
  • [8] Prospects of viral vector-mediated delivery of sequences encoding anti-HBV designer endonucleases
    Jacobs, Ridhwaanah
    Singh, Prashika
    Smith, Tiffany
    Arbuthnot, Patrick
    Maepa, Mohube Betty
    GENE THERAPY, 2025, 32 (01) : 8 - 15
  • [9] A novel, small anti-HBV compound reduces HBsAg and HBV-DNA by destabilizing HBV-RNA
    Watanabe, Takehisa
    Hayashi, Sanae
    Zhaoyu, Yan
    Inada, Hiroki
    Nagaoka, Katsuya
    Tateyama, Masakuni
    Tanaka, Yasuhito
    JOURNAL OF GASTROENTEROLOGY, 2024, 59 (04) : 315 - 328
  • [10] Control strategy design for the anti-HBV mathematical model
    Ding, Yi
    Wang, Wen-June
    IET SYSTEMS BIOLOGY, 2019, 13 (04) : 186 - 193